The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bms france; MSD Oncology; Novartis
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech; Roche/Genentech
Differential gradients of efficacy of immunotherapy according to the sun-exposure pattern of the site of occurrence of primary melanoma: A multicenter prospective cohort study (MELBASE).
 
David Russo
No Relationships to Disclose
 
Stéphane Dalle
Employment - Sanofi Pasteur (I)
Stock and Other Ownership Interests - Sanofi (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); MSD (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Olivier Dereure
Research Funding - Innate Pharma (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Laurent Mortier
No Relationships to Disclose
 
Sophie Dalac
No Relationships to Disclose
 
Caroline Dutriaux
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Marie Thérèse Leccia
No Relationships to Disclose
 
Delphine Legoupil
Consulting or Advisory Role - Bms; MSD; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Pierre Fabre
 
Henri Montaudie
Consulting or Advisory Role - BMS; MSD Oncology; NOVARTIS; Pierre Fabre
Research Funding - BMS (Inst); LEO Pharma (Inst)
Travel, Accommodations, Expenses - BMS; Novartis; Pierre Fabre
 
Eve Maubec
Consulting or Advisory Role - MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Pierre Fabre
 
Julie De Quatrebarbes
Speakers' Bureau - BMS; Janssen-Cilag
Travel, Accommodations, Expenses - BMS Brazil; MSD Oncology
 
Jean-Philippe Arnault
No Relationships to Disclose
 
Florence Granel Brocard
No Relationships to Disclose
 
Philippe Saiag
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Brigitte Dréno
Consulting or Advisory Role - Almirall; Bristol-Myers Squibb; Pierre Fabre; Roche/Genentech; Sun Pharma
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Clara Allayous
No Relationships to Disclose
 
Bastien Oriano
No Relationships to Disclose
 
Wendy Lefevre
No Relationships to Disclose
 
Celeste Lebbe
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi
Other Relationship - Avantis Medical Systems
 
Lise Boussemart
Stock and Other Ownership Interests - Cureety
Honoraria - Amgen; Bristol-Myers Squibb; Foundation Medicine; MSD; Novartis; Pierre Fabre